AI Boom Drives Surge in Forever Chemical Production

A growing number of major chemical manufacturers are planning to expand their output of per- and polyfluoroalkyl substances, or PFAS, to meet surging demand from the artificial intelligence sector. These compounds, often referred to as forever chemicals because they do not break down in the environment, are increasingly viewed by industry leaders as essential for powering next-generation data centers and semiconductor fabrication. However, health advocates argue that this expansion poses a severe threat to public safety and the planet, creating a conflict between technological progress and environmental protection.

The push to increase production is driven largely by the need for efficient cooling systems in data centers, which consume vast amounts of electricity and water. Many companies are framing these investments as part of a necessary industrial revolution, citing the role of PFAS in making hardware more energy-efficient. Yet, critics point out that while these chemicals may reduce operational costs for tech firms, they introduce long-term liabilities related to health risks and environmental cleanup that could far outweigh the immediate benefits.

Manufacturers Expand for Data Center Needs

A survey conducted by the Swedish chemicals watchdog ChemSec found that nearly all of the ten largest PFAS producers have plans to increase manufacturing capacity. Sites across Europe, Asia, and North America are set to see this growth. Major players such as Daikin, Arkema, and Chemours have explicitly linked their expansion strategies to the AI boom. For instance, Arkema is building a new production unit in Kentucky to supply refrigerants for data center cooling, while Chemours is targeting advanced hardware markets with liquid cooling solutions.

These companies argue that their products offer significant efficiencies in energy and water usage compared to traditional cooling methods. They present PFAS-based systems as a solution to the physical constraints of scaling AI infrastructure. However, this narrative sits in tension with recent legal setbacks for some producers. Chemours, for example, recently agreed to pay a substantial settlement in a lawsuit over PFAS discharges, a fact that critics say contradicts their claims of environmental responsibility.

Health Risks Outweigh Economic Gains

The core concern for campaigners is that PFAS are linked to serious health issues, including cancer, and persist indefinitely in nature. Anne-Sofie Bäckar, executive director of ChemSec, warns that without strict regulatory intervention, the industry is creating a ticking time bomb. The organization argues that increased production undermines early efforts to restrict these chemicals in Europe, the UK, and parts of the United States. The risk is not just local contamination but a global accumulation of toxins that will require expensive and complex remediation in the future.

Analysts note that PFAS are deeply integrated into semiconductor manufacturing, appearing in up to 1,000 distinct steps in chip production. This deep integration makes them difficult to remove quickly. While the AI industry benefits from improved performance and lower operating costs, the long-term financial and social costs of managing these persistent pollutants remain a hidden risk. The trade-off involves shifting health and environmental burdens from the present to future generations.

Few Companies Break From Trend

While most major producers are expanding, a few notable exceptions exist. The Swiss company Archroma is actively marketing PFAS-free alternatives, and the German giant BASF has announced plans to exit PFAS production entirely by 2028. These moves suggest that a shift is possible, but it remains a minority position in an industry dominated by growth strategies tied to the AI and electric vehicle sectors. Gujarat Fluorochemicals, another major player, has identified batteries and green hydrogen as additional growth areas, further entrenching the use of these chemicals across multiple high-growth industries.

According to reporting by GN technics/ai (en-US), the divergence between industry expansion and public health concerns highlights a critical regulatory gap. Governments and regulators are under pressure to decide whether to mandate a rapid phaseout or allow the market to drive further adoption. The outcome will determine whether the AI revolution comes with a legacy of persistent pollution or a transition to safer, non-persistent alternatives.